_id
69185ccb3c536f8df2317cc0
Ticker
0QLQ.LSE
Name
Ypsomed Holding AG
Exchange
LSE
Address
Brunnmattstrasse 6, Burgdorf, Switzerland, 3401
Country
UK
Sector
Industry
Currency
GBP
Website
https://www.ypsomed.com
Description
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
Last Close
306.3748665
Volume
261
Current Price
334.5
Change
0.1531393568147014
Last Updated
2025-12-29T14:36:27.685Z
Image
https://logo.clearbit.com/www.ypsomed.com
Ipo Date
-
Market Cap
4081612544
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
362688000
Cost Of Revenue
212490000
Gross Profit
150198000
Operating Expenses
75153000
Operating Income
75045000
Interest Expense
2380000
Pretax Income
147261000
Net Income
139094000
Eps
10.187393132126447
Dividends Per Share
30021000
Shares Outstanding
12603000
Income Tax Expense
8167000
EBITDA
186857000
Operating Margin
20.691338009528852
Total Other Income Expense Net
72216000
Cash
36301000
Short Term Investments
-
Receivables
176544000
Inventories
69394000
Total Current Assets
369986000
Property Plant Equipment
614518000
Total Assets
1208679000
Payables
22922000
Short Term Debt
10000000
Long Term Debt
-
Total Liabilities
401491000
Equity
807188000
Bs_currency_symbol
-
Depreciation
37216000
Change In Working Capital
-16510000
Cash From Operations
130378999
Capital Expenditures
126315999
Cash From Investing
157487000
Cash From Financing
-287361000
Net Change In Cash
-194000
Cf_currency_symbol
-
PE
1.7866
PB
5.658049672443099
ROE
17.231921188124698
ROA
11.507935522996595
FCF
4063000
Fcf Percent
0.011202466031409918
Piotroski FScore
3
Health Score
64
Deep Value Investing Score
7.5
Defensive Investing Score
7
Dividend Investing Score
3.5
Economic Moat Investing Score
10
Garp Investing Score
9.5
Growth Investing Score
7.5
Momentum Investing Score
4
Net Net Investing Score
4
Quality Investing Score
9
Value Investing Score
7.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
362688000
Quarters > 0 > income Statement > cost Of Revenue
212490000
Quarters > 0 > income Statement > gross Profit
150198000
Quarters > 0 > income Statement > operating Expenses
75153000
Quarters > 0 > income Statement > operating Income
75045000
Quarters > 0 > income Statement > interest Expense
2380000
Quarters > 0 > income Statement > pretax Income
147261000
Quarters > 0 > income Statement > net Income
139094000
Quarters > 0 > income Statement > eps
10.187393132126447
Quarters > 0 > income Statement > dividends Per Share
30021000
Quarters > 0 > income Statement > shares Outstanding
13653542
Quarters > 0 > income Statement > income Tax Expense
8167000
Quarters > 0 > income Statement > EBITDA
186857000
Quarters > 0 > income Statement > operating Margin
20.691338009528852
Quarters > 0 > income Statement > total Other Income Expense Net
72216000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
36301000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
176544000
Quarters > 0 > balance Sheet > inventories
69394000
Quarters > 0 > balance Sheet > total Current Assets
369986000
Quarters > 0 > balance Sheet > property Plant Equipment
614518000
Quarters > 0 > balance Sheet > total Assets
1208679000
Quarters > 0 > balance Sheet > payables
22922000
Quarters > 0 > balance Sheet > short Term Debt
10000000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
401491000
Quarters > 0 > balance Sheet > equity
807188000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
139094000
Quarters > 0 > cash Flow > depreciation
37216000
Quarters > 0 > cash Flow > change In Working Capital
-16510000
Quarters > 0 > cash Flow > cash From Operations
130378999
Quarters > 0 > cash Flow > capital Expenditures
126315999
Quarters > 0 > cash Flow > cash From Investing
157487000
Quarters > 0 > cash Flow > cash From Financing
-287361000
Quarters > 0 > cash Flow > net Change In Cash
-194000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
10.187393132126447
Quarters > 0 > ratios > PB
5.658049672443099
Quarters > 0 > ratios > ROE
17.231921188124698
Quarters > 0 > ratios > ROA
11.507935522996595
Quarters > 0 > ratios > FCF
4063000
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
0.011202466031409918
Quarters > 0 > health Score
64
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
212430500
Quarters > 1 > income Statement > cost Of Revenue
125111000
Quarters > 1 > income Statement > gross Profit
87319500
Quarters > 1 > income Statement > operating Expenses
51148500
Quarters > 1 > income Statement > operating Income
36171000
Quarters > 1 > income Statement > interest Expense
3832000
Quarters > 1 > income Statement > pretax Income
34009000
Quarters > 1 > income Statement > net Income
27452000
Quarters > 1 > income Statement > eps
2.0106806606681213
Quarters > 1 > income Statement > dividends Per Share
1000
Quarters > 1 > income Statement > shares Outstanding
13653088
Quarters > 1 > income Statement > income Tax Expense
6557000
Quarters > 1 > income Statement > EBITDA
44080000
Quarters > 1 > income Statement > operating Margin
17.027215960043403
Quarters > 1 > income Statement > total Other Income Expense Net
-2162000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
36495000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
203481000
Quarters > 1 > balance Sheet > inventories
85755000
Quarters > 1 > balance Sheet > total Current Assets
426948000
Quarters > 1 > balance Sheet > property Plant Equipment
545814000
Quarters > 1 > balance Sheet > total Assets
1330341000
Quarters > 1 > balance Sheet > payables
37368000
Quarters > 1 > balance Sheet > short Term Debt
267000000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
650656000
Quarters > 1 > balance Sheet > equity
679685000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
27452000
Quarters > 1 > cash Flow > depreciation
21203500
Quarters > 1 > cash Flow > change In Working Capital
-34829500
Quarters > 1 > cash Flow > cash From Operations
81304000
Quarters > 1 > cash Flow > capital Expenditures
53532000
Quarters > 1 > cash Flow > cash From Investing
-138198000
Quarters > 1 > cash Flow > cash From Financing
40705000
Quarters > 1 > cash Flow > net Change In Cash
-15819000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
2.0106806606681213
Quarters > 1 > ratios > PB
6.7192271949506015
Quarters > 1 > ratios > ROE
4.038929798362477
Quarters > 1 > ratios > ROA
2.063531079625449
Quarters > 1 > ratios > FCF
27772000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.13073452258503368
Quarters > 1 > health Score
56
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
212430500
Quarters > 2 > income Statement > cost Of Revenue
125111000
Quarters > 2 > income Statement > gross Profit
87319500
Quarters > 2 > income Statement > operating Expenses
51148500
Quarters > 2 > income Statement > operating Income
36171000
Quarters > 2 > income Statement > interest Expense
1624000
Quarters > 2 > income Statement > pretax Income
34009000
Quarters > 2 > income Statement > net Income
27452000
Quarters > 2 > income Statement > eps
2.0106806606681213
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
13653088
Quarters > 2 > income Statement > income Tax Expense
6557000
Quarters > 2 > income Statement > EBITDA
44080000
Quarters > 2 > income Statement > operating Margin
17.027215960043403
Quarters > 2 > income Statement > total Other Income Expense Net
-2162000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
36495000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
173901000
Quarters > 2 > balance Sheet > inventories
85755000
Quarters > 2 > balance Sheet > total Current Assets
426948000
Quarters > 2 > balance Sheet > property Plant Equipment
558068000
Quarters > 2 > balance Sheet > total Assets
1330341000
Quarters > 2 > balance Sheet > payables
37368000
Quarters > 2 > balance Sheet > short Term Debt
267000000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
650654000
Quarters > 2 > balance Sheet > equity
679687000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
27452000
Quarters > 2 > cash Flow > depreciation
21203500
Quarters > 2 > cash Flow > change In Working Capital
-34829500
Quarters > 2 > cash Flow > cash From Operations
40652000
Quarters > 2 > cash Flow > capital Expenditures
53532000
Quarters > 2 > cash Flow > cash From Investing
-69099000
Quarters > 2 > cash Flow > cash From Financing
20352500
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
2.0106806606681213
Quarters > 2 > ratios > PB
6.719207423416955
Quarters > 2 > ratios > ROE
4.038917913686741
Quarters > 2 > ratios > ROA
2.063531079625449
Quarters > 2 > ratios > FCF
-12880000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
-0.06063159480394764
Quarters > 2 > health Score
45
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
162002500
Quarters > 3 > income Statement > cost Of Revenue
103289500
Quarters > 3 > income Statement > gross Profit
58713000
Quarters > 3 > income Statement > operating Expenses
38458500
Quarters > 3 > income Statement > operating Income
20254500
Quarters > 3 > income Statement > interest Expense
3507000
Quarters > 3 > income Statement > pretax Income
18148000
Quarters > 3 > income Statement > net Income
16300000
Quarters > 3 > income Statement > eps
1.193749148629825
Quarters > 3 > income Statement > dividends Per Share
13650000
Quarters > 3 > income Statement > shares Outstanding
13654460
Quarters > 3 > income Statement > income Tax Expense
1848000
Quarters > 3 > income Statement > EBITDA
44139500
Quarters > 3 > income Statement > operating Margin
12.502584836653755
Quarters > 3 > income Statement > total Other Income Expense Net
-2106500
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
52314000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
141356000
Quarters > 3 > balance Sheet > inventories
81332000
Quarters > 3 > balance Sheet > total Current Assets
341105000
Quarters > 3 > balance Sheet > property Plant Equipment
495191000
Quarters > 3 > balance Sheet > total Assets
1180970000
Quarters > 3 > balance Sheet > payables
25112000
Quarters > 3 > balance Sheet > short Term Debt
325190000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
559106000
Quarters > 3 > balance Sheet > equity
621864000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
16300000
Quarters > 3 > cash Flow > depreciation
18767500
Quarters > 3 > cash Flow > change In Working Capital
-7682500
Quarters > 3 > cash Flow > cash From Operations
66896000
Quarters > 3 > cash Flow > capital Expenditures
49269000
Quarters > 3 > cash Flow > cash From Investing
-129073000
Quarters > 3 > cash Flow > cash From Financing
41542000
Quarters > 3 > cash Flow > net Change In Cash
-21703000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
1.193749148629825
Quarters > 3 > ratios > PB
7.344719858361313
Quarters > 3 > ratios > ROE
2.6211518917319543
Quarters > 3 > ratios > ROA
1.3802213434718917
Quarters > 3 > ratios > FCF
17627000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.10880696285551149
Quarters > 3 > health Score
52
Annuals > 0 > quarter
2025-03-31
Annuals > 0 > income Statement > revenue
748866000
Annuals > 0 > income Statement > cost Of Revenue
456801000
Annuals > 0 > income Statement > gross Profit
292066000
Annuals > 0 > income Statement > operating Expenses
179214000
Annuals > 0 > income Statement > operating Income
112851000
Annuals > 0 > income Statement > interest Expense
6644000
Annuals > 0 > income Statement > pretax Income
104315000
Annuals > 0 > income Statement > net Income
87504000
Annuals > 0 > income Statement > eps
6.408777529201816
Annuals > 0 > income Statement > dividends Per Share
27299000
Annuals > 0 > income Statement > shares Outstanding
13653774
Annuals > 0 > income Statement > income Tax Expense
16810000
Annuals > 0 > income Statement > EBITDA
190901000
Annuals > 0 > income Statement > operating Margin
15.069585212841815
Annuals > 0 > income Statement > total Other Income Expense Net
-8536000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
36495000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
203481000
Annuals > 0 > balance Sheet > inventories
85755000
Annuals > 0 > balance Sheet > total Current Assets
426948000
Annuals > 0 > balance Sheet > property Plant Equipment
545814000
Annuals > 0 > balance Sheet > total Assets
1330341000
Annuals > 0 > balance Sheet > payables
37368000
Annuals > 0 > balance Sheet > short Term Debt
267000000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
650656000
Annuals > 0 > balance Sheet > equity
679685000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
87504000
Annuals > 0 > cash Flow > depreciation
79942000
Annuals > 0 > cash Flow > change In Working Capital
-66238000
Annuals > 0 > cash Flow > cash From Operations
148200000
Annuals > 0 > cash Flow > capital Expenditures
277149000
Annuals > 0 > cash Flow > cash From Investing
-267271000
Annuals > 0 > cash Flow > cash From Financing
82247000
Annuals > 0 > cash Flow > net Change In Cash
-37522000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
6.408777529201816
Annuals > 0 > ratios > PB
6.538769337266529
Annuals > 0 > ratios > ROE
12.874199077513849
Annuals > 0 > ratios > ROA
6.577561692829131
Annuals > 0 > ratios > FCF
-128949000
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
-0.17219235484051887
Annuals > 0 > health Score
55
Annuals > 1 > quarter
2024-03-31
Annuals > 1 > income Statement > revenue
548457000
Annuals > 1 > income Statement > cost Of Revenue
359403000
Annuals > 1 > income Statement > gross Profit
189054000
Annuals > 1 > income Statement > operating Expenses
102835000
Annuals > 1 > income Statement > operating Income
86219000
Annuals > 1 > income Statement > interest Expense
5038000
Annuals > 1 > income Statement > pretax Income
81872000
Annuals > 1 > income Statement > net Income
78366000
Annuals > 1 > income Statement > eps
5.7403629571300385
Annuals > 1 > income Statement > dividends Per Share
17745000
Annuals > 1 > income Statement > shares Outstanding
13651750
Annuals > 1 > income Statement > income Tax Expense
3506000
Annuals > 1 > income Statement > EBITDA
161556000
Annuals > 1 > income Statement > operating Margin
15.720284361399345
Annuals > 1 > income Statement > total Other Income Expense Net
-4347000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
74017000
Annuals > 1 > balance Sheet > short Term Investments
575000
Annuals > 1 > balance Sheet > receivables
141033000
Annuals > 1 > balance Sheet > inventories
75286000
Annuals > 1 > balance Sheet > total Current Assets
337945000
Annuals > 1 > balance Sheet > property Plant Equipment
445291000
Annuals > 1 > balance Sheet > total Assets
1101395000
Annuals > 1 > balance Sheet > payables
30884000
Annuals > 1 > balance Sheet > short Term Debt
181194000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
483661000
Annuals > 1 > balance Sheet > equity
617734000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
78366000
Annuals > 1 > cash Flow > depreciation
74866000
Annuals > 1 > cash Flow > change In Working Capital
-46102000
Annuals > 1 > cash Flow > cash From Operations
163224000
Annuals > 1 > cash Flow > capital Expenditures
195312000
Annuals > 1 > cash Flow > cash From Investing
-195072000
Annuals > 1 > cash Flow > cash From Financing
81066000
Annuals > 1 > cash Flow > net Change In Cash
48793000
Annuals > 1 > cash Flow > currency_symbol
CHF
Annuals > 1 > ratios > PE
5.7403629571300385
Annuals > 1 > ratios > PB
7.1934596849129235
Annuals > 1 > ratios > ROE
12.686042859871725
Annuals > 1 > ratios > ROA
7.115158503534154
Annuals > 1 > ratios > FCF
-32088000
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
-0.058505953976337254
Annuals > 1 > health Score
55
Annuals > 2 > quarter
2023-03-31
Annuals > 2 > income Statement > revenue
497460000
Annuals > 2 > income Statement > cost Of Revenue
356869000
Annuals > 2 > income Statement > gross Profit
140591000
Annuals > 2 > income Statement > operating Expenses
79998000
Annuals > 2 > income Statement > operating Income
60594000
Annuals > 2 > income Statement > interest Expense
2310000
Annuals > 2 > income Statement > pretax Income
56637000
Annuals > 2 > income Statement > net Income
51275000
Annuals > 2 > income Statement > eps
3.8211708440081433
Annuals > 2 > income Statement > dividends Per Share
8189999
Annuals > 2 > income Statement > shares Outstanding
13418662
Annuals > 2 > income Statement > income Tax Expense
5362000
Annuals > 2 > income Statement > EBITDA
137507000
Annuals > 2 > income Statement > operating Margin
12.1806778434447
Annuals > 2 > income Statement > total Other Income Expense Net
-3957000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
24477000
Annuals > 2 > balance Sheet > short Term Investments
747000
Annuals > 2 > balance Sheet > receivables
108389000
Annuals > 2 > balance Sheet > inventories
57704000
Annuals > 2 > balance Sheet > total Current Assets
208327000
Annuals > 2 > balance Sheet > property Plant Equipment
379587000
Annuals > 2 > balance Sheet > total Assets
861879000
Annuals > 2 > balance Sheet > payables
19620000
Annuals > 2 > balance Sheet > short Term Debt
133082000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
299548000
Annuals > 2 > balance Sheet > equity
562333000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
51275000
Annuals > 2 > cash Flow > depreciation
44353000
Annuals > 2 > cash Flow > change In Working Capital
-22633000
Annuals > 2 > cash Flow > cash From Operations
129531000
Annuals > 2 > cash Flow > capital Expenditures
98878000
Annuals > 2 > cash Flow > cash From Investing
-122019000
Annuals > 2 > cash Flow > cash From Financing
1265000
Annuals > 2 > cash Flow > net Change In Cash
8186000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
3.8211708440081433
Annuals > 2 > ratios > PB
7.767238417450158
Annuals > 2 > ratios > ROE
9.118262666427187
Annuals > 2 > ratios > ROA
5.949210968128937
Annuals > 2 > ratios > FCF
30653000
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
0.061619024645197605
Annuals > 2 > health Score
55
Annuals > 3 > quarter
2022-03-31
Annuals > 3 > income Statement > revenue
464841000
Annuals > 3 > income Statement > cost Of Revenue
351024000
Annuals > 3 > income Statement > gross Profit
113817000
Annuals > 3 > income Statement > operating Expenses
85238000
Annuals > 3 > income Statement > operating Income
28579000
Annuals > 3 > income Statement > interest Expense
2265000
Annuals > 3 > income Statement > pretax Income
25540000
Annuals > 3 > income Statement > net Income
23105000
Annuals > 3 > income Statement > eps
1.8215905587919239
Annuals > 3 > income Statement > dividends Per Share
14667000
Annuals > 3 > income Statement > shares Outstanding
12683970
Annuals > 3 > income Statement > income Tax Expense
2435000
Annuals > 3 > income Statement > EBITDA
96660000
Annuals > 3 > income Statement > operating Margin
6.14812376705153
Annuals > 3 > income Statement > total Other Income Expense Net
-3039000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
15859000
Annuals > 3 > balance Sheet > short Term Investments
1179000
Annuals > 3 > balance Sheet > receivables
97658000
Annuals > 3 > balance Sheet > inventories
68299000
Annuals > 3 > balance Sheet > total Current Assets
193584000
Annuals > 3 > balance Sheet > property Plant Equipment
327945000
Annuals > 3 > balance Sheet > total Assets
756910000
Annuals > 3 > balance Sheet > payables
17386000
Annuals > 3 > balance Sheet > short Term Debt
137456000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
364371000
Annuals > 3 > balance Sheet > equity
392540000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
23105000
Annuals > 3 > cash Flow > depreciation
40304000
Annuals > 3 > cash Flow > change In Working Capital
-22350999
Annuals > 3 > cash Flow > cash From Operations
85706000
Annuals > 3 > cash Flow > capital Expenditures
51592000
Annuals > 3 > cash Flow > cash From Investing
-125700000
Annuals > 3 > cash Flow > cash From Financing
38125000
Annuals > 3 > cash Flow > net Change In Cash
-2282000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
1.8215905587919239
Annuals > 3 > ratios > PB
10.517736370815713
Annuals > 3 > ratios > ROE
5.886024354205941
Annuals > 3 > ratios > ROA
3.0525425744143955
Annuals > 3 > ratios > FCF
34114000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.07338853500444238
Annuals > 3 > health Score
52
Valuation > metrics > PE
1.7866
Valuation > metrics > PB
5.658049672443099
Valuation > final Score
43.419503275569014
Valuation > verdict
3.2% Overvalued
Profitability > metrics > ROE
17.231921188124698
Profitability > metrics > ROA
37.59439546361214
Profitability > metrics > Net Margin
0.383508690665255
Profitability > final Score
94
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
0.497394658988984
Risk > metrics > Interest Coverage
31.531512605042018
Risk > final Score
100
Risk > verdict
Low
Liquidity > metrics > Current Ratio
11.238260130004253
Liquidity > metrics > Quick Ratio
9.130429500030376
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
40
Prev Valuations > 2
40
Prev Profitabilities > 0
47
Prev Profitabilities > 1
47
Prev Profitabilities > 2
35
Prev Risks > 0
86
Prev Risks > 1
88
Prev Risks > 2
71
Prev Liquidities > 0
85
Prev Liquidities > 1
85
Prev Liquidities > 2
47
Updated At
2026-01-20T22:57:31.772Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-05-20
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
Stock Price
£0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very High
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Ypsomed Holding AG
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-09-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.